Selective immunoglobulin A deficiency

54,701views

Selective immunoglobulin A deficiency

step 1 hemato

step 1 hemato

Blood histology
Blood components
Erythropoietin
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Iron deficiency anemia
Beta-thalassemia
Alpha-thalassemia
Sideroblastic anemia
Anemia of chronic disease
Lead poisoning
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Pyruvate kinase deficiency
Paroxysmal nocturnal hemoglobinuria
Sickle cell disease (NORD)
Hereditary spherocytosis
Aplastic anemia
Megaloblastic anemia
Vitamin B12 deficiency
Acute intermittent porphyria
Porphyria cutanea tarda
Hemophilia
Vitamin K deficiency
Hemolytic-uremic syndrome
Immune thrombocytopenia
Thrombotic thrombocytopenic purpura
Von Willebrand disease
Heparin-induced thrombocytopenia
Antithrombin III deficiency
Antiphospholipid syndrome
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelodysplastic syndromes
Polycythemia vera (NORD)
Myelofibrosis (NORD)
Essential thrombocythemia (NORD)
Langerhans cell histiocytosis
Multiple myeloma
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Hematopoietic medications
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Transplant rejection
Graft-versus-host disease
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Isolated primary immunoglobulin M deficiency
Thymic aplasia
DiGeorge syndrome
Severe combined immunodeficiency
Adenosine deaminase deficiency
Ataxia-telangiectasia
Hyper IgM syndrome
Wiskott-Aldrich syndrome
Leukocyte adhesion deficiency
Chediak-Higashi syndrome
Chronic granulomatous disease
Complement deficiency
Asplenia
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Glucocorticoids
Folate (Vitamin B9) deficiency
Cell cycle
Contact dermatitis
Atopic dermatitis
Bullous pemphigoid
Pemphigus vulgaris
Erythema multiforme
Stevens-Johnson syndrome
HIV and AIDS: Pathology review
Tuberculosis: Pathology review

Transcript

Watch video only

Selective immunoglobulin A deficiency is a condition where there’s a lack of immunoglobulin or antibody A, called IgA for short. It’s called “selective” because all the other antibody classes, IgM, IgG, IgE and IgD are produced normally. IgA is in charge of protecting the mucosal surfaces of the body against foreign invaders, so without it, there’s a higher risk of mucosal infections.

Now, B cells make antibodies, and normally, B cells are “born” in the bone marrow, which is the spongy tissue inside some bones of the body. This is where they develop their B cell receptors on their surface which eventually can get released - and when they’re freely floating in the blood they’re called antibodies.

Antibodies are Y- shaped protein molecules, formed by two heavy and two light chains, each of which has a variable region, at one end, and a constant region (C region) at the other end. Variable regions are unique to each B cell and they are designed to bind to a very specific antigen, whereas C regions determine the antibody class.

Initially all of the B cells have IgM and IgD class antibodies on their surface, with each B cell recognizing and binding to its own unique antigen. Mature B cells leave the bone marrow and migrate to peripheral lymphoid organs, like the spleen, lymph nodes or mucosa-associated lymphoid tissue, which is also called MALT.

MALT is composed of clusters of lymphoid tissue scattered under the mucous membranes lining the mouth, airways, and digestive tract. This is a really strategic position, because a variety of antigens are constantly being picked up and filtered from these body tissues. As a result, B cells are likely to encounter an antigen they recognize. A bit like spending time at a train station during rush hour to look for someone that catches your eye.

If two of a B cell’s receptors bind to the same antigen, they can cross-link - meaning that two adjacent receptors on the B cell surface can get pulled close together. When that happens the B cell will often take in the antigen, digest it, and present pieces of it on another cell surface protein called a major histocompatibility class II molecule, or MHC class II.

If a nearby T cell receptor recognizes this antigen bound to an MHC class II molecule, the T cell releases cytokines that make the B cell differentiate into a plasma cell, which is a cell that makes lots of antibodies.

The specific set of cytokines received by the B cell determine how it class-switches, meaning whether it switches from making IgM and IgD to making IgG, IgE or IgA. In class switching, what changes is only the constant region, and not the variable region of the antibody, meaning that the antigen specificity remains the same.

IgA is primarily produced when B cells are stimulated by interleukin- 5 (IL-5) or transforming growth factor- β or TGF- β. Class switching to IgA usually happens in mucosa-associated lymphoid tissue, or MALT, from where IgA is secreted into the saliva, sweat, or intestinal juices.

When IgA is secreted, it’s called secretory IgA, and it’s a dimer, meaning that two IgA molecules are joined together by a joining chain or J chain. This J chain is recognized by a poly-Ig receptor on the basolateral side of the mucous membrane, which helps it move across the epithelial cells and into the lumen.

Key Takeaways

Selective IgA deficiency is a common cause of immunodeficiency caused by low amounts of immunoglobulin A (IgA), resulting in low protection against infections of the mucous membranes lining the respiratory and gastrointestinal tracts. It is typically accompanied by normal levels of IgM, IgD, and IgG, and slightly elevated levels of IgE. Affected people are susceptible to infections of the mucous membranes lining the mouth, airways, and digestive tract.

Selective IgA deficiency often results from a failure of B cells to differentiate into IgA-secreting plasma cells, so IgA remains bound to their surface, along with IgM and IgD. Most people with selective IgA deficiency generally appear healthy, with no major symptoms. Sometimes, however, they may have more chronic infections, an increased frequency of atopy and asthma, as well as autoimmune diseases like rheumatoid arthritis. Selective IgA deficiency is associated with an increased risk of some malignancies, like gastric and colon cancer.

Sources

  1. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  2. "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
  3. "Yen & Jaffe's Reproductive Endocrinology" Saunders W.B. (2018)
  4. "Bates' Guide to Physical Examination and History Taking" LWW (2016)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "Practice parameter for the diagnosis and management of primary immunodeficiency" Annals of Allergy, Asthma & Immunology (2005)
  7. "Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)" Clinical and Experimental Immunology (2000)
  8. "Update on the use of immunoglobulin in human disease: A review of evidence" Journal of Allergy and Clinical Immunology (2017)
  9. "Hypersensitivity transfusion reactions due to IgA deficiency are rare according to French hemovigilance data" Journal of Allergy and Clinical Immunology (2017)